AMOREPACIFIC Group (00279K)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 19,900.00 |
|---|---|
| 52-week range | 18,230.00 – 28,200.00 |
| Return, 1 month / 3 months | −8.1% / −2.7% |
| Return, 1 year / 3 years | −0.2% / +28.6% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 33.7% |
| Worst drawdown (1 year) | -32.2% |
| Average daily value traded | 90.85M KRW |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Amorepacific Group is a Korean holding company for a family of businesses centred on beauty and personal care. Its affiliates develop and market skincare, makeup, fragrance and hair and body products under a range of brands, serving consumers in Korea and in overseas markets through department stores, specialty retailers and online channels. The group also has interests in household goods and health-related products, and it is based in Seoul, Korea.
AMOREPACIFIC Group trades under the code 00279K on the Korea Stock Exchange in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AMOREPACIFIC Group (00279K) trades on the Korea Stock Exchange in Korea. It last closed at KRW 19,900.00 on 23 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 294 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.2% and over the last three months it fell 2.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -9.0% | ||
| From 52-week high | -28.8% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.7% | ||
| 6-month return | -14.8% | ||
| 12-month return, skipping the last month | 8.6% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.2% | ||
| Liquidity | 19 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 90.85M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.2% |
|---|---|
| 1 month | −8.1% |
| 3 months | −2.7% |
| 6 months | −14.8% |
| 1 year | −0.2% |
| 3 years | +28.6% |
| 5 years | −40.4% |
Signals
| 50-day / 200-day average | 21,418.00 / 21,872.67 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 554.61 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Mar 2026 | KRW 667.0000 |
| 27 Mar 2025 | KRW 667.0000 |
| 27 Dec 2023 | KRW 667.0000 |
| 28 Dec 2022 | KRW 667.0000 |
| 29 Dec 2021 | KRW 667.0000 |
| 29 Dec 2020 | KRW 751.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.